ClinConnect ClinConnect Logo
Search / Trial NCT05216666

The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty

Launched by SAHLGRENSKA UNIVERSITY HOSPITAL · Jan 27, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Abductor Approach Limp Trendelenburg Gluteus Medius

ClinConnect Summary

This clinical trial is studying how different surgical techniques used during total hip replacement (also known as total hip arthroplasty) might affect the likelihood of having a limp one year after the surgery. Specifically, it compares the lateral approach (where the surgeon makes an incision on the side of the hip) to the posterior approach (where the incision is made at the back of the hip). The goal is to see which method may lead to less limping after the operation, especially for patients with hip osteoarthritis.

To participate in this trial, you need to be an adult scheduled for a total hip replacement due to primary hip osteoarthritis and be able to read and write in Swedish. However, if you have issues with the other hip or knee that cause limping, certain neuromuscular diseases, or significant leg length differences after surgery, you won't be eligible. If you join, you can expect to be monitored for a year after your surgery to see how well you recover and whether you experience any limping. This research could help improve surgical techniques and outcomes for future patients undergoing hip replacement.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Primary unilateral osteoarthritis of the hip scheduled for total hip arthroplasty.
  • Ability to understand and write swedish.
  • Exclusion Criteria:
  • Impaired funktion of the contralateral hip or knees causing limping.
  • Neuromuscular diseases
  • Postoperative leg length discrepancy excceding 1 cm
  • Postoperative discrepancy in femoral offset exceeding 25% of the femoral offset of the contralateral hip.

About Sahlgrenska University Hospital

Sahlgrenska University Hospital, a leading healthcare institution in Sweden, is at the forefront of clinical research and innovation. Affiliated with the University of Gothenburg, the hospital integrates advanced medical care with cutting-edge research, facilitating a collaborative environment for scientific exploration and clinical trials. With a commitment to improving patient outcomes, Sahlgrenska University Hospital focuses on a wide range of therapeutic areas, leveraging its multidisciplinary expertise to advance healthcare solutions. The institution is dedicated to fostering ethical research practices and ensuring the highest standards of patient safety and care in all clinical trials.

Locations

Mölndal, , Sweden

Patients applied

0 patients applied

Trial Officials

Georgios Tsikandylakis, MD PhD

Principal Investigator

Sahlgrenska University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials